REQUEST A DEMO
Total
USD $0.00
Search more companies

KORONA-PHARMA BT. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: KORONA-PHARMA BT. Profile Updated: September 26, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Hungarian Download a sample report

KORONA-PHARMA BT. is an enterprise located in Hungary, with the main office in Nyiregyhaza. The enterprise operates in the Pharmacies and Drug Stores industry. It was incorporated on April 02, 1996. There are currently 19 (2024) people employed by KORONA-PHARMA BT.. In 2024, the company reported a net sales revenue increase of 18.56%. Its’ total assets recorded a negative growth of 11%. KORONA-PHARMA BT.’s net profit margin decreased by 0.01% in 2024.

Headquarters
Szabadsag ter 12/A.
Nyiregyhaza; Szabolcs-Szatmar-Bereg; Postal Code: 4400

Contact Details: Purchase the KORONA-PHARMA BT. report to view the information.

Basic Information
Total Employees:
Purchase the KORONA-PHARMA BT. report to view the information.
Registered Capital:
Purchase the KORONA-PHARMA BT. report to view the information.
Financial Auditors:
Purchase the KORONA-PHARMA BT. report to view the information.
Incorporation Date:
April 02, 1996
Key Executives
Purchase this report to view the information.
Executive Officer
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
VIRIDIS-PHARMA KFT.
Company Performance
Financial values in the chart are available after KORONA-PHARMA BT. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
18.56%
Total operating revenue
18.68%
Operating profit (EBIT)
204.55%
EBITDA
56.05%
Net Profit (Loss) for the Period
17.25%
Total Assets
-11%
Total Equity
7.16%
Operating Profit Margin (ROS)
0.66%
Net Profit Margin
-0.01%
Return on Equity (ROE)
0.58%
Quick Ratio
0.02%
Cash Ratio
0.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?